SCHEMBL22573508

SCHEMBL22573508

Cc1cccnc1NC(=O)c1cnc(-c2ccccc2)nc1N

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.57
▸ L3MBTL1 Q9Y468 2/20 0.57
▸ ALDH1A1 P00352 5/20 0.55
▸ RAB9A P51151 4/20 0.55
▸ MAPT P10636 4/20 0.55
▸ NPC1 O15118 3/20 0.55
▸ SMN1; SMN2 Q16637 3/20 0.55
▸ TP53 P04637 2/20 0.55
▸ SORT1 Q99523 1/20 0.50
▸ LMNA P02545 3/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ HTT P42858 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ ADORA3 P0DMS8 1/20 0.48
▸ ADORA2A P29274 1/20 0.48
▸ ADORA2B P29275 1/20 0.48
▸ ADORA1 P30542 1/20 0.48
▸ HPGD P15428 2/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ CYP1A2 P05177 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22573340 0.92 L3MBTL1 (0.53) KMT2AL3MBTL1ALDH1A1RAB9AMAPT
SCHEMBL22573734 0.91 KMT2A (0.52) KMT2AL3MBTL1ALDH1A1RAB9AMAPT
SCHEMBL22573747 0.87 L3MBTL1 (0.56) KMT2AL3MBTL1ALDH1A1RAB9AMAPT
SCHEMBL22573595 0.84 MAPT (0.58) KMT2AALDH1A1RAB9AMAPTNPC1
SCHEMBL22573404 0.82 ADORA2A (0.71) KMT2AL3MBTL1ALDH1A1RAB9AMAPT
SCHEMBL22573798 0.79 ALDH1A1 (0.61) KMT2AL3MBTL1ALDH1A1RAB9AMAPT
SCHEMBL22573967 0.79 ATR (0.66) ALDH1A1RAB9AMAPTNPC1SMN1; SMN2
SCHEMBL22573719 0.79 LMNA (0.62) KMT2AL3MBTL1ALDH1A1RAB9AMAPT
SCHEMBL22573371 0.79 MAPT (0.58) KMT2AALDH1A1RAB9AMAPTNPC1
SCHEMBL22573541 0.76 ALDH1A1 (0.61) KMT2AL3MBTL1ALDH1A1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3728236-A1 PYRIMIDINE DERIVATIVES AND THEIR USE USE FOR THE TREATMENT OF CANCER Adorx therapeutics Limited (GB) 2020-10-28 — — EP claimed
EP-3728236-A1 PYRIMIDINE DERIVATIVES AND THEIR USE USE FOR THE TREATMENT OF CANCER Adorx therapeutics Limited (GB) 2020-10-28 — — EP disclosed
Send feedback